Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02676115 · ClinicalTrials.gov registry record · NA

Medipore Tape Study

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT02676115 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02676115, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This is a prospective, single-blinded, two-arm, randomized, parallel, pragmatic, effectiveness trial that will enroll patients undergoing arthroscopic anterior cruciate ligament reconstruction in order to evaluate the efficacy of using Medipore tape to improve cosmetic wound healing and scaring.

Interventions

  • OTHER Standard Post Operative Skin Care
  • OTHER Medipore Tape

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2015-02
Est. Completion 2016-02
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT02676115

The ClinicalTrials.gov registry entry for NCT02676115 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard Post Operative Skin Care is the first listed.

NCT02676115 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02676115 about?

NCT02676115 is a clinical study titled "Medipore Tape Study". This is a prospective, single-blinded, two-arm, randomized, parallel, pragmatic, effectiveness trial that will enroll patients undergoing arthroscopic anterior cruciate ligament reconstruction in order to evaluate the efficacy of using Medipore tape to improve cosmetic wound healing and scaring.

What is the current status of trial NCT02676115?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-02. Estimated completion is 2016-02.

What interventions are being tested in trial NCT02676115?

The interventions under investigation include: Standard Post Operative Skin Care (OTHER), Medipore Tape (OTHER).

Who is sponsoring clinical trial NCT02676115?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.